Cara Therapeutics (CARA) PT Raised to $39 at Piper Jaffray
Tweet
Share
E-mailGet Alerts CARA Hot Sheet
Price: $5.32 --0%
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Piper Jaffray analyst David Amsellem raised the price target on Cara Therapeutics (NASDAQ: CARA) to $39.00 (from $35.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Tingyi Cayman Islands Holding Corp. (322:HK) (TCYMY) PT Raised to HK$11.60 at Macquarie
- JPMorgan Downgrades Denso Corp. (6902:JP) (DNZOY) to Underweight
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
